Ipsen has become an active dealmaker as it pursues growth in oncology, and its latest move is the $450 million acquisition of Kartos Therapeutics, a clinical-stage biotech whose lead program

Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several

AI tools are quickly creating new opportunities for innovation in the medical world, which could provide much-needed support to specialities like radiology where clinicians suffer from systemic burnout and workforce

The flux around CMS Star Ratings continues. Lawsuits from health insurers over Medicare Advantage Star Ratings have increased in recent years, though with varying results. Some plans like SCAN and

A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this inflammatory disorder and one offering key competitive advantages over the

Healthcare has spent the better part of a decade building data lakes. The original problem was straightforward and worth solving: clinical data lived in silos, providers could not see the

Healthcare has gotten good at finishing things. Discharge instructions are handed over. Follow-ups are scheduled. Portal accounts are created. Bills go out on time. Every one of those is a

A few years ago, I started experiencing symptoms I couldn’t explain, and no one could explain them either. Fatigue that wouldn’t lift, heart palpitations, an inability to lose weight regardless

A group of Democratic senators introduced a new bill on Thursday that would create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries. The Medicare Cost Cap Act was

Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory. The move follows an FDA proposal